Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study - EClinicalMedicine
Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects | HTML
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder | SpringerLink
Complement activation and the mechanism of action of Eculizumab. The AP... | Download Scientific Diagram
Figure 1 from Eculizumab: A Review in Generalized Myasthenia Gravis | Semantic Scholar
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab | SpringerLink
Frontiers | Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics | Immunology
Soliris® (eculizumab) HCP | Mechanism of Action
Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review - Devalet - 2015 - European Journal of Haematology - Wiley Online Library
An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document | Nefrología
Eculizumab - Dubois - 2009 - British Journal of Clinical Pharmacology - Wiley Online Library
The complement cascade and the C5 blockade by eculizumab. Eculizumab... | Download Scientific Diagram
Advances in the Management of atypical Haemolytic Uraemic Syndrome (aHUS) Soliris® (eculizumab, rmc) is indicated for the treatment of patients with. - ppt download
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria
Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review - Devalet - 2015 - European Journal of Haematology - Wiley Online Library
Complement activation and the mechanism of action of Eculizumab. The AP... | Download Scientific Diagram
Akari Therapeutics - Set up to compete in the Soliris market and more | Edison
Eculizumab Overview - Creative Biolabs
Soliris® (eculizumab) HCP | Mechanism of Action
Eculizumab: the molecule. The structure of the anti-complement 5... | Download Scientific Diagram
Eculizumab - YouTube
Eculizumab | Nature Reviews Drug Discovery
Infectious Risks Associated with Biologics Targeting Janus Kinase-Signal Transducer and Activator of Transcription Signaling and Complement Pathway for Inflammatory Diseases - Infectious Disease Clinics
Soliris® (eculizumab) HCP | Mechanism of Action
